Nuclear factor-κB activation by type II collagen peptide in articular chondrocytes: its inhibition by hyaluronan via the receptors

References

• Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol. 2006; 16:197–205.
   PubMedGoogle Scholar
• Homandberg GA. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci. 1999; 4:D713–D730.
   PubMedGoogle Scholar
• Dahlberg L, Billinghurst C, Manner P, Nelson F, Webb G, Ionescu M, et al. Collagenase-mediated cleavage of type II collagen is selectively enhanced in osteoarthritis cartilage and can be arrested with a synthetic inhibitor which spares collagenase-1 (MMP-1). Arthr Rheum. 2000; 43:673–682.
   PubMed Web of Science ®Google Scholar
• Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest. 1994; 93:1722–1732.
   PubMed Web of Science ®Google Scholar
• Jennings L, Wu L, King KB, Hämmerle H, Cs-Szabo G, Mollenhauser J. The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect Tissue Res. 2001; 42:71–86.
   PubMed Web of Science ®Google Scholar
• Fichter M, Körner U, Schömburg J, Jennings L, Cole AA, Mollenhauer J. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes. J Orthop Res. 2006; 24:63–70.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu WC, Mousa A, et al. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biol. 2006; 25:419–429.
   PubMed Web of Science ®Google Scholar
• Tchetina EV, Kobayashi M, Yasuda T, Meijers T, Pidoux I, Poole AR. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis. Matrix Biol. 2007; 26:247–258.
   PubMed Web of Science ®Google Scholar
• Finco TS, Baldwin AS Jr. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 1995; 3:263–272.
   PubMed Web of Science ®Google Scholar
• Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996; 14:649–683.
   PubMed Web of Science ®Google Scholar
• Pulai JI, Chen H, Im H-J, Kumar S, Hanning C, Hedge PS, et al. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol. 2005; 174:5781–5788.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Nakamura T. Inhibition of nuclear factor-κB by hyaluronan in rheumatoid chondrocytes stimulated with COOH-terminal heparin-binding fibronectin fragment. Mod Rheumatol. 2007; 17:391–397.
   PubMedGoogle Scholar
• Ding L, Guo D, Homandberg GA. Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through praline rich tyrosine kinase 2, c-src, NF-κB and protein kinase Cδ. Osteoarthr Cartil. 2009; 17:1385–1392.
   PubMedGoogle Scholar
• Salter DM, Godolphin JL, Gourlay MS, Lawson MF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol. 1996; 179:396–402.
   PubMed Web of Science ®Google Scholar
• Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986; 137:245–254.
   PubMed Web of Science ®Google Scholar
• Davies ME, Dingle JT, Pigott R, Power C, Sharma H. Expression of intercellular adhesion molecule 1 (ICAM-1) on human articular cartilage chondrocytes. Connect Tissue Res. 1991; 26:207–216.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi SM, Hiramitsu T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol. 2003; 30:1164–1172.
   PubMed Web of Science ®Google Scholar
• Julovi SM, Yasuda T, Shimizu M, Hiramitsu T, Nakamura T. Inhibition of interleukin-1β-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthr Rheum. 2004; 50:516–525.
   PubMedGoogle Scholar
• Kang Y, Eger W, Koepp H, Williams JM, Kuettner KE, Homandberg GA. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthop Res. 1999; 17:858–869.
   PubMedGoogle Scholar
• Yasuda T. Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragment. Clin Rheumatol. 2010; 29:1259–1267.
   PubMedGoogle Scholar
• Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-κB and p38. Rheumatology. 2006; 45:824–832.
   PubMedGoogle Scholar
• Yasuda T. Activation of p38 mitogen-activated protein kinase is inhibited by hyaluronan via ICAM-1 in articular chondrocytes stimulated with type II collagen peptide. J Pharmacol Sci.. 2012; 118:25–32.
   Google Scholar
• Steen PE, Proost P, Grillet B, Brand DD, Kang AH, Damar J, et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002; 16:379–389.
   PubMedGoogle Scholar
• Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthr Rheum. 1986; 29:1039–1049.
   PubMed Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Laurent AE, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985; 44:817–822.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase-3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthr Rheum. 2000; 43:801–811.
   PubMed Web of Science ®Google Scholar
• Knudson CB. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol. 1993; 120:825–834.
   PubMed Web of Science ®Google Scholar
• Chow G, Nietfeld JJ, Knudson CB, Knudson W. Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthr Rheum. 1998; 41:1411–1419.
   PubMed Web of Science ®Google Scholar
• Nishida Y, D’Souza AL, Thonar EJ, Knudson W. Stimulation of hyaluronan metabolism by interleukin-1α in human articular cartilage. Arthr Rheum. 2000; 43:1315–1326.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Kakinuma T, Julovi SM, Yoshida M, Hiramitsu T, Akiyoshi M, et al. COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology. 2004; 43:1116–1120.
   PubMed Web of Science ®Google Scholar
• Holmes MW, Bayliss MT, Muir H. Hyaluronic acid in human articular cartilage. Age-related changes in content and size. Biochem J. 1988; 250:435–441.
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011; 91:221–264.
   PubMed Web of Science ®Google Scholar
• Knudson CB, Knudson W. Hyaluronan and CD44. Clin Orthop. 2004; 427S:S152–S162.
   Google Scholar
• Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T, et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2009; 68:1051–1058.
   PubMed Web of Science ®Google Scholar
• Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthr Rheum. 2001; 44:1800–1807.
   PubMed Web of Science ®Google Scholar
• Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992; 116:817–825.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Roth J. Mechanisms of disease: a ‘DAMP’ view of inflammatory arthritis. Nat Clin Pract Rheumatol. 2007; 3:382–390.
   PubMedGoogle Scholar
• Zhang Q, Hui W, Litherland GJ, Barter MJ, Davidson R, Darrah C, et al. Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis. 2008; 67:1633–1641.
   PubMedGoogle Scholar
• O’Neill LA. How Toll-like receptors signal: what we know and what we don’t know. Curr Opin Immunol. 2006; 18:3–9.
   PubMed Web of Science ®Google Scholar
• Rowan AD, Young DA. Collagenase gene regulation by pro-inflammatory cytokines in cartilage. Front Biosci. 2007; 12:536–550.
   PubMed Web of Science ®Google Scholar